Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nurix Therapeutics, Inc. | 31,250 | reported | 15 May 2026 | tx 6+158,750 |
| Rapport Therapeutics, Inc. | 10,925 | reported | 17 Jun 2025 | tx 2+40,681 |
| VERTEX PHARMACEUTICALS INC / MA | 10,115 | reported | 01 Mar 2021 | tx 560+705,043−687,977 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 May 2026 | GRANT_AWARD | Nurix Therapeutics, Inc. | 31,250 | 0.00 USD | deriv |
| 17 Jun 2025 | GRANT_AWARD | Rapport Therapeutics, Inc. | 10,925 | 0.00 USD | deriv |
| 19 May 2025 | GRANT_AWARD | Nurix Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 07 Nov 2024 | GRANT_AWARD | Rapport Therapeutics, Inc. | 29,756 | 0.00 USD | deriv |
| 20 May 2024 | GRANT_AWARD | Nurix Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 04 May 2023 | GRANT_AWARD | Nurix Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 05 May 2022 | GRANT_AWARD | Nurix Therapeutics, Inc. | 17,500 | 0.00 USD | deriv |
| 01 Oct 2021 | GRANT_AWARD | Nurix Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 01 Mar 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 1,026 | 210.13 USD | |
| 01 Mar 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 610 | 211.45 USD | |
| 01 Mar 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 915 | 212.51 USD | |
| 01 Mar 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 231 | 213.12 USD | |
| 26 Feb 2021 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 2,218 | 212.42 USD | |
| 25 Feb 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 258 | 214.32 USD | |
| 25 Feb 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 452 | 213.12 USD | |
| 25 Feb 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 244 | 211.80 USD | |
| 24 Feb 2021 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 864 | 217.57 USD | |
| 25 Feb 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 126 | 216.25 USD | |
| 18 Feb 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 2,343 | 211.82 USD | |
| 18 Feb 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 584 | 210.05 USD | |
| 18 Feb 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 1,368 | 212.62 USD | |
| 17 Feb 2021 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 2,740 | 211.75 USD | |
| 11 Feb 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 1,288 | 210.45 USD | |
| 11 Feb 2021 | SALE | VERTEX PHARMACEUTICALS INC / MA | 210 | 211.32 USD | |
| 10 Feb 2021 | TAX_WITHHOLDING | VERTEX PHARMACEUTICALS INC / MA | 651 | 214.16 USD |